Real-World Duration of Venetoclax Treatment for Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia (CLL/SLL)
07:30am - 03:45pm EST - April 1, 2023
07:30am - 03:45pm EST - April 1, 2023
Author(s):
- Dr. Anna Teschemaker, PhD, Associate Director, Oncology Outcomes Research, AstraZeneca Pharmaceuticals, LP
Tags: Outcomes and Health Services Research
| Display Label | Action |
|---|---|
| AC23P120 - Real-World Duration of Venetoclax Treatment for Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia (CLL/SLL) | Download MP3 |
| 120-General Poster Session | Download Handout |